Outstanding results from CLARITY: a new CLL combination therapy
IDH inhibition in AML therapy
PHILEMON: a step closer to using MRD to guide treatment decisions in mantle cell lymphoma (MCL)?
Remission maintenance with histamine dihydrochloride (HDC)/IL-2 therapy in AML
The changing definition of complete remission in multiple myeloma
Carlos Fernandez de Larrea